| Dr David S Lewin, MD | |
|
11800 Southwest Hwy, Palos Heights, IL 60463-1029 | |
| (708) 361-0220 | |
| (708) 923-3611 |
| Full Name | Dr David S Lewin |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 32 Years |
| Location | 11800 Southwest Hwy, Palos Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316950223 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Hospital | Zanesville, OH | Hospital |
| Marietta Memorial Hospital | Marietta, OH | Hospital |
| Mercyone Waterloo Medical Center | Waterloo, IA | Hospital |
| Avita Ontario | Ontario, OH | Hospital |
| Riverside Methodist Hospital | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lucidsolutions Inc | 0749603462 | 65 |
| Riverside Radiology And Interventional Associates Inc | 8729976964 | 206 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs.
Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma's hypothesis that pressure has a clear relation with the most optimal results in mammography.
On April 21, 1994, two-year-old Stuart Herriott succumbed to head injuries after an accident and his parents consented to organ donation. His heart, liver and both kidneys were transplanted. Sixteen years later, the Herriott family, including Stuart's aunt, Linda Rumble, will be among the many supporters of organ and tissue donation gathering on both sides of the Canada -US boarder today to help raise awareness of the continuing need for organ and tissue donors.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
› Verified 2 days ago
| Entity Name | Rockford Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs.
Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma's hypothesis that pressure has a clear relation with the most optimal results in mammography.
On April 21, 1994, two-year-old Stuart Herriott succumbed to head injuries after an accident and his parents consented to organ donation. His heart, liver and both kidneys were transplanted. Sixteen years later, the Herriott family, including Stuart's aunt, Linda Rumble, will be among the many supporters of organ and tissue donation gathering on both sides of the Canada -US boarder today to help raise awareness of the continuing need for organ and tissue donors.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
› Verified 2 days ago
| Entity Name | Mercy Health System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031111000307 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs.
Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma's hypothesis that pressure has a clear relation with the most optimal results in mammography.
On April 21, 1994, two-year-old Stuart Herriott succumbed to head injuries after an accident and his parents consented to organ donation. His heart, liver and both kidneys were transplanted. Sixteen years later, the Herriott family, including Stuart's aunt, Linda Rumble, will be among the many supporters of organ and tissue donation gathering on both sides of the Canada -US boarder today to help raise awareness of the continuing need for organ and tissue donors.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
› Verified 2 days ago
| Entity Name | Integrated Imaging Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700285335 PECOS PAC ID: 2567784408 Enrollment ID: O20141204001441 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs.
Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma's hypothesis that pressure has a clear relation with the most optimal results in mammography.
On April 21, 1994, two-year-old Stuart Herriott succumbed to head injuries after an accident and his parents consented to organ donation. His heart, liver and both kidneys were transplanted. Sixteen years later, the Herriott family, including Stuart's aunt, Linda Rumble, will be among the many supporters of organ and tissue donation gathering on both sides of the Canada -US boarder today to help raise awareness of the continuing need for organ and tissue donors.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
› Verified 2 days ago
| Entity Name | Lucidsolutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518594480 PECOS PAC ID: 0749603462 Enrollment ID: O20210122000956 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs.
Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma's hypothesis that pressure has a clear relation with the most optimal results in mammography.
On April 21, 1994, two-year-old Stuart Herriott succumbed to head injuries after an accident and his parents consented to organ donation. His heart, liver and both kidneys were transplanted. Sixteen years later, the Herriott family, including Stuart's aunt, Linda Rumble, will be among the many supporters of organ and tissue donation gathering on both sides of the Canada -US boarder today to help raise awareness of the continuing need for organ and tissue donors.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
› Verified 2 days ago
| Entity Name | Riverside Radiology And Interventional Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093718496 PECOS PAC ID: 8729976964 Enrollment ID: O20210204000100 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs.
Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma's hypothesis that pressure has a clear relation with the most optimal results in mammography.
On April 21, 1994, two-year-old Stuart Herriott succumbed to head injuries after an accident and his parents consented to organ donation. His heart, liver and both kidneys were transplanted. Sixteen years later, the Herriott family, including Stuart's aunt, Linda Rumble, will be among the many supporters of organ and tissue donation gathering on both sides of the Canada -US boarder today to help raise awareness of the continuing need for organ and tissue donors.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David S Lewin, MD 2300 N Lincoln Park W, #622, Chicago, IL 60614-3456 Ph: (773) 909-0379 | Dr David S Lewin, MD 11800 Southwest Hwy, Palos Heights, IL 60463-1029 Ph: (708) 361-0220 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs.
Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma's hypothesis that pressure has a clear relation with the most optimal results in mammography.
On April 21, 1994, two-year-old Stuart Herriott succumbed to head injuries after an accident and his parents consented to organ donation. His heart, liver and both kidneys were transplanted. Sixteen years later, the Herriott family, including Stuart's aunt, Linda Rumble, will be among the many supporters of organ and tissue donation gathering on both sides of the Canada -US boarder today to help raise awareness of the continuing need for organ and tissue donors.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
› Verified 2 days ago
Dr. Jon Randal Jester, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Community Hospital, Palos Heights, IL 60463 Phone: 708-923-4000 Fax: 708-923-3189 | |
Dr. Michael G Horton, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-4000 Fax: 708-923-3189 | |
Dr. Sandra Willner Horowitz, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 11800 Southwest Hwy, Palos Heights, IL 60463 Phone: 708-361-0220 Fax: 708-923-3611 | |
Dr. Faisal Sabir Vali, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11800 Southwest Hwy, Radiation Oncology, Palos Heights, IL 60463 Phone: 708-923-3285 | |
Dr. Paresh Dixit, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 12251 S. 80th Ave, Palos Community Hospital, Palos Heights, IL 60463 Phone: 708-923-4000 Fax: 708-448-6350 | |
Dr. Gregory J Ostrowski, Radiology Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Community Hospital, Palos Heights, IL 60463 Phone: 708-923-4000 Fax: 708-448-6350 |